New Drug Applications Archive - February 2004
Get news by email or subscribe to our news feeds.
February 2, 2004
- Yamanouchi Pharma America Submits New Drug Application to the FDA for Conivaptan Hydrochloride to treat Hyponatremia
- Mylan Laboratories and Watson Pharmaceuticals Announce Receipt of "Approvable" Letter for Emsam
- Mylan Laboratories and Watson Pharmaceuticals Announce Receipt of “Approvable” Letter for Emsam
February 3, 2004
February 4, 2004
February 6, 2004
- Aventis and Genta Announce FDA Acceptance and Priority Review of New Drug Application for Genasense in Advanced Melanoma
- Aventis' Dermik Laboratories Announces FDA Acceptance of Filing For Sculptra to Treat Facial Lipoatrophy
- Review of ISTA Pharmaceuticals' New Drug Application for Vitrase for Use as a Spreading Agent Extended 90 Days by FDA
